EIGRQ — Eiger Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Eiger Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	95	129	88.8	98.9	25.4
Net Total Accounts Receivable
Net Total Receivables	—	—	2.58	1.75	1.68
Total Inventory
Prepaid Expenses
Total Current Assets	100	138	103	118	37.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.24	1.89	1.27	1.26	0.627
Long Term Investments
Other Long Term Assets
Total Assets	105	144	126	120	38.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	16.9	16.6	29.9	25.1	53.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	48.7	48.6	54	64.8	53.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	56.5	95	72.4	55.3	-14.5
Total Liabilities & Shareholders' Equity	105	144	126	120	38.8
Total Common Shares Outstanding